
    
      Study Type: Interventional Study Design: Randomized, 2-period, 2-sequence, crossover design.

      Official Title: Randomized, 2-way crossover, bioequivalence study of Fentanyl 25 μg/h
      transdermal system and Duragesic 25 μg/h transdermal system administrated as 1 x 25 μg/h
      single application in the healthy subjects

      Further study details as provided by Actavis Elizabeth LLC:

      Primary Outcome Measures:

      Rate and Extend of Absorption
    
  